Javascript must be enabled to continue!
Sulfonic Acid Derivative-Modified SBA-15, PHTS and MCM-41 Mesoporous Silicas as Carriers for a New Antiplatelet Drug: Ticagrelor Adsorption and Release Studies
View through CrossRef
Three mesoporous, siliceous materials, i.e., SBA-15 (Santa Barbara Amorphous), PHTS (Plugged Hexagonal Templated Silica) and MCM-41 (Mobil Composition of Matter), functionalized with a sulfonic acid derivative, were successfully prepared and applied as the carriers for the poorly water-soluble drug, ticagrelor. The siliceous carriers were characterized using nitrogen sorption analysis, X-ray diffraction (XRD), transmission electron microscopy (TEM) and elemental analysis. The adsorption studies were conducted in acetonitrile. At the highest equilibrium concentrations, the amount of ticagrelor Qe that adsorbed onto the examined silicas was in the range of 83 to 220 mg/g, increasing in the following order: PHTS-(CH2)3-SO3H < SBA-15-(CH2)3-SO3H < MCM-41-(CH2)3-SO3H. The equilibrium adsorption data were analyzed using the Freundlich, Jovanovich, Langmuir, Temkin, Dubinin-Radushkevich, Dubinin-Astakhov and Redlich-Peterson models. In order to find the best-fit isotherm for each model, a nonlinear fitting analysis was carried out. Based on the minimized values of the ARE function, the fit of the isotherms to the experimental points for ticagrelor adsorption onto the modified silicas can be ordered as follows: SBA-15-(CH2)3-SO3H (Redlich-Peterson > Dubinin-Astakhov > Temkin), PHTS-(CH2)3-SO3H (Redlich-Peterson > Temkin > Dubinin-Astakhov), MCM-41-(CH2)3-SO3H (Redlich-Peterson > Dubinin-Astakhov > Langmuir). The values of adsorption energy (above 8 kJ/mol) indicate the chemical nature of ticagrelor adsorption onto propyl-sulfonic acid-modified silicas. The results of release studies indicated that at pH 4.5, modified SBA-15 and MCM-41 carriers accelerate the drug dissolution process, compared to the dissolution rate of free crystalline ticagrelor. Intriguingly, modified PHTS silica provides prolonged drug release kinetics compared to other siliceous adsorbents and to the dissolution rate of crystalline ticagrelor. A Weibull release model was employed to describe the release profiles of ticagrelor from the prepared carriers. The time necessary to dissolve 50% and 90% of ticagrelor from mesoporous adsorbents at pH 4.5 increased in the following order: SBA-15-(CH2)3-SO3H < MCM-41-(CH2)3-SO3H < PHTS-(CH2)3-SO3H.
Title: Sulfonic Acid Derivative-Modified SBA-15, PHTS and MCM-41 Mesoporous Silicas as Carriers for a New Antiplatelet Drug: Ticagrelor Adsorption and Release Studies
Description:
Three mesoporous, siliceous materials, i.
e.
, SBA-15 (Santa Barbara Amorphous), PHTS (Plugged Hexagonal Templated Silica) and MCM-41 (Mobil Composition of Matter), functionalized with a sulfonic acid derivative, were successfully prepared and applied as the carriers for the poorly water-soluble drug, ticagrelor.
The siliceous carriers were characterized using nitrogen sorption analysis, X-ray diffraction (XRD), transmission electron microscopy (TEM) and elemental analysis.
The adsorption studies were conducted in acetonitrile.
At the highest equilibrium concentrations, the amount of ticagrelor Qe that adsorbed onto the examined silicas was in the range of 83 to 220 mg/g, increasing in the following order: PHTS-(CH2)3-SO3H < SBA-15-(CH2)3-SO3H < MCM-41-(CH2)3-SO3H.
The equilibrium adsorption data were analyzed using the Freundlich, Jovanovich, Langmuir, Temkin, Dubinin-Radushkevich, Dubinin-Astakhov and Redlich-Peterson models.
In order to find the best-fit isotherm for each model, a nonlinear fitting analysis was carried out.
Based on the minimized values of the ARE function, the fit of the isotherms to the experimental points for ticagrelor adsorption onto the modified silicas can be ordered as follows: SBA-15-(CH2)3-SO3H (Redlich-Peterson > Dubinin-Astakhov > Temkin), PHTS-(CH2)3-SO3H (Redlich-Peterson > Temkin > Dubinin-Astakhov), MCM-41-(CH2)3-SO3H (Redlich-Peterson > Dubinin-Astakhov > Langmuir).
The values of adsorption energy (above 8 kJ/mol) indicate the chemical nature of ticagrelor adsorption onto propyl-sulfonic acid-modified silicas.
The results of release studies indicated that at pH 4.
5, modified SBA-15 and MCM-41 carriers accelerate the drug dissolution process, compared to the dissolution rate of free crystalline ticagrelor.
Intriguingly, modified PHTS silica provides prolonged drug release kinetics compared to other siliceous adsorbents and to the dissolution rate of crystalline ticagrelor.
A Weibull release model was employed to describe the release profiles of ticagrelor from the prepared carriers.
The time necessary to dissolve 50% and 90% of ticagrelor from mesoporous adsorbents at pH 4.
5 increased in the following order: SBA-15-(CH2)3-SO3H < MCM-41-(CH2)3-SO3H < PHTS-(CH2)3-SO3H.
Related Results
Fabrication of the Ordered Mesoporous nZVI/Zr-Ce-SBA-15 Composites Used for Crystal Violet Removal and Their Optimization Using RSM and ANN–PSO
Fabrication of the Ordered Mesoporous nZVI/Zr-Ce-SBA-15 Composites Used for Crystal Violet Removal and Their Optimization Using RSM and ANN–PSO
Crystal violet (CV), a triphenylmethane dye, is widely used in the textile, printing, paper, leather, and cosmetics industries. However, due to its higher chemical stability and lo...
Competition for MCM Loading at Origins Establishes Replication Timing Patterns
Competition for MCM Loading at Origins Establishes Replication Timing Patterns
Abstract
Loading of the MCM replicative helicase onto origins of replication is a highly regulated process that precedes DNA replication in all eukaryotes. The numb...
Abstract 9497: Dose Reduction of Ticagrelor in Ticagrelor Hyper-responders: A Pharmacokinetics and Pharmacodynamics (pkpd) Study
Abstract 9497: Dose Reduction of Ticagrelor in Ticagrelor Hyper-responders: A Pharmacokinetics and Pharmacodynamics (pkpd) Study
Introduction:
Ticagrelor has demonstrated superiority to Clopidogrel in reducing major adverse cardiovascular events, but at the cost of higher bleeding risk. However, ...
Ticagrelor inverse agonist activity at the P2Y12 receptor is non-reversible versus its endogenous agonist ADP.
Ticagrelor inverse agonist activity at the P2Y12 receptor is non-reversible versus its endogenous agonist ADP.
Background: Ticagrelor is labelled as a reversible, direct-acting
platelet P2Y12 receptor (P2Y12R) antagonist that is indicated clinically
for the prevention of thrombotic events i...
The Adsorption of Pentachlorophenol from Aqueous Solutions onto Exchanged Al-MCM-41 Materials
The Adsorption of Pentachlorophenol from Aqueous Solutions onto Exchanged Al-MCM-41 Materials
The ability of a mesoporous molecular sieve to adsorb chlorinated phenols was studied experimentally. Thus, the adsorption isotherms of pentachlorophenol (PCP) from aqueous solutio...
TGFβ1 Cell Cycle Arrest Is Mediated by Inhibition of MCM Assembly in Rb-Deficient Conditions
TGFβ1 Cell Cycle Arrest Is Mediated by Inhibition of MCM Assembly in Rb-Deficient Conditions
Abstract
Transforming growth factor β1 (TGFβ1) is a potent inhibitor of cell growth that targets gene-regulatory events, but al...
Ticagrelor Use and Practice Pattern among Canadian Cardiac Surgeons
Ticagrelor Use and Practice Pattern among Canadian Cardiac Surgeons
Background and Aim: The P2Y12 platelet receptor inhibitor ticagrelor is
widely used in patients following acute coronary syndromes or in those
who have received coronary stents. Be...
Adsorption of Rhodamine-B (RhB) and Regeneration of MCM-41 Mesoporous Silica
Adsorption of Rhodamine-B (RhB) and Regeneration of MCM-41 Mesoporous Silica
Rhodamine (RhB) adsorption was carried out on MCM-41 and MCM-41 calcined. The effect of parameters such as pH was investigated. The reusability potential of MCM-41 was also establi...

